Oral Dutasteride as a First-Line Treatment for Frontal Fibrosing Alopecia

    February 2025 in “ Journal of the European Academy of Dermatology and Venereology ”
    Sergio Vañó‐Galván, Cristina Pindado‐­Ortega, David Saceda‐Corralo
    Studysummary This article reviews current therapeutic strategies for frontal fibrosing alopecia and discusses the potential of oral dutasteride as a first-line treatment, emphasizing the need for more clinical trials.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Reply To: Oral Dutasteride Is A First-Line Treatment For Frontal Fibrosing Alopecia – There Is Insufficient Evidence To Recommend Dutasteride As First-Line Treatment In Frontal Fibrosing Alopecia Journal of the European Academy of Dermatology and Venereology · 2024
    2. Analysis of Breast Health Outcomes in Women on Oral 5-Alpha Reductase Inhibitors: A Single-Center Retrospective Cohort Study Journal of the American Academy of Dermatology · 2024
    3. Oral Dutasteride Is a First-Line Treatment for Frontal Fibrosing Alopecia Journal of the European Academy of Dermatology and Venereology · 2024
    4. Response to Effectiveness of Dutasteride in a Large Series of Patients with Frontal Fibrosing Alopecia in Real Clinical Practice 2021
    5. Association of Inflammation With Progression of Hair Loss in Women With Frontal Fibrosing Alopecia JAMA dermatology · 2020
    6. Frontal Fibrosing Alopecia: A Retrospective Review of 19 Patients Seen at Duke University Journal of The American Academy of Dermatology · 2013
    7. Frontal Fibrosing Alopecia in Postmenopausal Women Journal of The American Academy of Dermatology · 2004